Sleep TMS for Depression

ConditionsMajor Depression Sleep

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorStanford University

About this trial

The goal of this study is to establish the feasibility, tolerability, and preliminary efficacy of sleep-state transcranial magnetic stimulation (TMS) for enhancing plasticity in depression treatment.

Eligibility criteria

Qualifiers

Adults ages 18-65 years

Current Major Depressive Disorder (MDD) diagnosis

Failed ≥1 antidepressant medication

Moderate-to-severe depression

Disqualifiers

Intellectual disability

Significant head injury/neurological disorder

Pregnancy or postpartum

TMS/MRI contraindications

Trial design

Treatments tested in this trial

Treatment groups

55 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Stanford University

Lead sponsor

National Center for Advancing Translational Sciences (NCATS)

Collaborator

National Institute of Mental Health (NIMH)

Collaborator

Source ClinicalTrials.gov